Dow Down 0.02% Nasdaq Up 0.07%

Neuralstem, Inc. (CUR)

-NYSE MKT
2.79 Nov 25, 4:01PM EST
Prev Close:2.79
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:7.00
Beta:2.49
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:2.12 - 4.81
Volume:0
Avg Vol (3m):548,689
Market Cap:243.73M
P/E (ttm):N/A
EPS (ttm):-0.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CUR 0.00%243.73M
GERN564.39M
STEM78.35M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14,624.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback